Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-03-13 | Mr. Alan Leonard SmithSenior MD & Chief HR Officer | -3,85k | 88,53k | Sale to Issuer | 23,00 | 14,49k | -20,99% |
| 2026-02-28 | Ms. Terry Gibson VacheronInitié | -2,85k | 74,89k | Sale to Issuer | 26,26 | 19,57k | -12,72% |
| 2026-02-28 | Mr. Alan Leonard SmithSenior MD & Chief HR Officer | -4,01k | 105,41k | Sale to Issuer | 26,26 | 9,70k | -29,28% |
| 2026-02-28 | Mr. Douglas J. SharpSenior MD, Head of the Americas & EMEA & Chair of the Board of Invesco UK | -21,69k | 569,45k | Sale to Issuer | 26,26 | 40,12k | -35,09% |
| 2026-02-28 | Mr. Andrew Ryan SchlossbergPresident, CEO & Director | -94,00k | 2,47M | Sale to Issuer | 26,26 | 898,72k | -9,47% |
| 2026-02-28 | Mr. Jeffrey Howard KuporSenior MD, General Counsel & Company Secretary | -7,13k | 187,23k | Sale to Issuer | 26,26 | 151,82k | -4,49% |
| 2026-02-28 | Ms. Shannon Anastasia JohnstonSenior MD and Chief Information & Operations Officer | -3,97k | 104,25k | Sale to Issuer | 26,26 | 24,85k | -13,78% |
| 2026-02-28 | Ms. Laura Allison DukesSenior MD & CFO | -58,06k | 1,52M | Sale to Issuer | 26,26 | 342,26k | -14,50% |
| 2026-02-28 | Ms. Stephanie Claire ButcherSenior MD & Co-Head of Investment | -9,24k | 242,56k | Sale to Issuer | 26,26 | 20,62k | -30,94% |
| 2026-02-28 | Mr. Tony L. WongSenior MD & Co-Head of Investment | -17,85k | 468,85k | Sale to Issuer | 26,26 | 126,97k | -12,33% |
| 2026-02-06 | Mr. Tony L. WongSenior MD & Co-Head of Investment | -40,11k | 1,08M | Sale to Issuer | 26,82 | 112,87k | -26,22% |
| 2026-01-15 | Mr. Douglas J. SharpSenior MD, Head of the Americas & EMEA & Chair of the Board of Invesco UK | -13,72k | 403,20k | Sale to Issuer | 29,39 | 15,66k | -46,69% |
| 2025-12-11 | Mr. Andrew Ryan SchlossbergPresident, CEO & Director | -18,80k | 0,00 | Other Disposition | - | 814,08k | -2,26% |
| 2025-10-31 | Mr. Douglas J. SharpSenior MD, Head of the Americas & EMEA & Chair of the Board of Invesco UK | -160,00k | 3,77M | Vente | 23,56 | 192,00 | -99,88% |
| 2025-10-16 | Ms. Shannon Anastasia JohnstonSenior MD and Chief Information & Operations Officer | -8,35k | 190,27k | Sale to Issuer | 22,80 | 19,90k | -29,54% |
| 2025-09-10 | Ms. Stephanie Claire ButcherSenior MD & Co-Head of Investment | -103,19k | 2,28M | Vente | 22,12 | 29,86k | -77,56% |
| 2025-08-31 | Mr. Douglas J. SharpSenior MD, Head of the Americas & EMEA & Chair of the Board of Invesco UK | 29,98k | 0,00 | Derivative Exercise and Retained Stock | - | 160,19k | 23,03% |
| 2025-08-31 | Mr. Douglas J. SharpSenior MD, Head of the Americas & EMEA & Chair of the Board of Invesco UK | -26,59k | 582,08k | Derivative Exercise and Sale | 21,89 | 160,19k | - |
| 2025-08-31 | Ms. Stephanie Claire ButcherSenior MD & Co-Head of Investment | 23,68k | 0,00 | Derivative Exercise and Retained Stock | - | 133,05k | 21,65% |
| 2025-08-31 | Ms. Stephanie Claire ButcherSenior MD & Co-Head of Investment | -21,00k | 459,67k | Derivative Exercise and Sale | 21,89 | 133,05k | - |
| 2025-08-27 | Ms. Laura Allison DukesSenior MD & CFO | -34,76k | 0,00 | Other Disposition | - | 293,17k | -10,60% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
